These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28107674)

  • 1. Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma.
    Wang B; Wang W; Zhu Z; Zhang X; Tang F; Wang D; Liu X; Yan X; Zhuang H
    Clin Neurol Neurosurg; 2017 Mar; 154():28-33. PubMed ID: 28107674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.
    Ji L; Tang Y; Pang X; Zhang Y
    Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
    Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y
    Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
    Bernhardt S; Bayerlová M; Vetter M; Wachter A; Mitra D; Hanf V; Lantzsch T; Uleer C; Peschel S; John J; Buchmann J; Weigert E; Bürrig KF; Thomssen C; Korf U; Beissbarth T; Wiemann S; Kantelhardt EJ
    Breast Cancer Res; 2017 Oct; 19(1):112. PubMed ID: 29020998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients.
    Shi H; Fang X; Li Y; Zhang Y
    Med Sci Monit; 2019 Oct; 25():7430-7438. PubMed ID: 31581160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas.
    Wu M; Wanggou S; Li X; Liu Q; Xie Y
    Onco Targets Ther; 2017; 10():3781-3788. PubMed ID: 28794642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer proteome and metabolite changes linked to SHMT2.
    Tong J; Krieger JR; Taylor P; Bagshaw R; Kang J; Jeedigunta S; Wybenga-Groot LE; Zhang W; Badr H; Mirhadi S; Pham NA; Coyaud É; Yu M; Li M; Cabanero M; Raught B; Maynes JT; Hawkins C; Tsao MS; Moran MF
    PLoS One; 2020; 15(9):e0237981. PubMed ID: 32903271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of SHMT2 is correlated with tumor progression and predicts poor prognosis in gastrointestinal tumors.
    Liu Y; Yin C; Deng MM; Wang Q; He XQ; Li MT; Li CP; Wu H
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9379-9392. PubMed ID: 31773687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation.
    Yang X; Wang Z; Li X; Liu B; Liu M; Liu L; Chen S; Ren M; Wang Y; Yu M; Wang B; Zou J; Zhu WG; Yin Y; Gu W; Luo J
    Cancer Res; 2018 Jan; 78(2):372-386. PubMed ID: 29180469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance.
    Kim D; Fiske BP; Birsoy K; Freinkman E; Kami K; Possemato RL; Chudnovsky Y; Pacold ME; Chen WW; Cantor JR; Shelton LM; Gui DY; Kwon M; Ramkissoon SH; Ligon KL; Kang SW; Snuderl M; Vander Heiden MG; Sabatini DM
    Nature; 2015 Apr; 520(7547):363-7. PubMed ID: 25855294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF2 as a potential prognostic biomarker for proneural glioma patients.
    Sooman L; Freyhult E; Jaiswal A; Navani S; Edqvist PH; Pontén F; Tchougounova E; Smits A; Elsir T; Gullbo J; Lennartsson J; Bergqvist M; Ekman S
    Acta Oncol; 2015 Mar; 54(3):385-94. PubMed ID: 25263081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis.
    Wei Z; Song J; Wang G; Cui X; Zheng J; Tang Y; Chen X; Li J; Cui L; Liu CY; Yu W
    Nat Commun; 2018 Oct; 9(1):4468. PubMed ID: 30367038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of tissue microRNA10b may help predict glioma prognosis.
    Zhang X; Cheng J; Fu L; Li Q
    J Clin Neurosci; 2016 Jul; 29():59-63. PubMed ID: 26988656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma.
    Luo L; Zheng Y; Lin Z; Li X; Li X; Li M; Cui L; Luo H
    J Immunol Res; 2021; 2021():6647122. PubMed ID: 33928169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
    Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
    Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive correlation between expression level of mitochondrial serine hydroxymethyltransferase and breast cancer grade.
    Yin K
    Onco Targets Ther; 2015; 8():1069-74. PubMed ID: 25999742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological significance of epidermal growth factor receptor expression and amplification in human gliomas.
    Zhao LL; Xu KL; Wang SW; Hu BL; Chen LR
    Histopathology; 2012 Oct; 61(4):726-36. PubMed ID: 22978472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
    Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
    J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian target of rapamycin signaling pathway contributes to glioma progression and patients' prognosis.
    Yang J; Liao D; Wang Z; Liu F; Wu G
    J Surg Res; 2011 Jun; 168(1):97-102. PubMed ID: 20036387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine hydroxymethyltransferase 2: a novel target for human cancer therapy.
    Xie M; Pei DS
    Invest New Drugs; 2021 Dec; 39(6):1671-1681. PubMed ID: 34215932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.